KOPRAN

Kopran Share Price

₹202.75 -5.15 (-2.48%)

21 Nov, 2024 14:07

SIP TrendupStart SIP in KOPRAN

Start SIP

Performance

  • Low
  • ₹198
  • High
  • ₹207
  • 52 Week Low
  • ₹198
  • 52 Week High
  • ₹370
  • Open Price₹207
  • Previous Close₹208
  • Volume767,103

Investment Returns

  • Over 1 Month -36.64%
  • Over 3 Month -34.5%
  • Over 6 Month -18.66%
  • Over 1 Year -25.77%
SIP Lightning

Smart Investing Starts Here Start SIP with Kopran for Steady Growth!

Invest Now

Kopran Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 18.5
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 978
  • P/B Ratio
  • 2
  • Average True Range
  • 19.08
  • EPS
  • 10.97
  • Dividend Yield
  • 1.5
  • MACD Signal
  • -8.93
  • RSI
  • 22.96
  • MFI
  • 36.02

Kopran Financials

Kopran Technicals

EMA & SMA

Current Price
₹202.75
-5.15 (-2.48%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹275.93
  • 50 Day
  • ₹290.75
  • 100 Day
  • ₹287.82
  • 200 Day
  • ₹273.20

Resistance and Support

213.52 Pivot Speed
  • R3 244.53
  • R2 236.07
  • R1 221.98
  • S1 199.43
  • S2 190.97
  • S3 176.88

What's your outlook on Kopran?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Kopran Ltd. is a fully integrated pharmaceutical company, engaged in the manufacturing and marketing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company serves global markets with a focus on innovation, quality, and regulatory compliance.

Kopran has an operating revenue of Rs. 636.00 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 11% is healthy, ROE of 10% is good. The company has a reasonable debt to equity of 3%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 86 which is a GOOD score indicating consistency in earnings, a RS Rating of 6 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C+ which is evident from recent supply seen, Group Rank of 39 indicates it belongs to a strong industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Kopran Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-13 Quarterly Results
2024-08-08 Quarterly Results
2024-05-16 Audited Results & Final Dividend
2024-02-07 Quarterly Results
2023-11-07 Quarterly Results

Kopran F&O

Kopran Shareholding Pattern

44.49%
0%
0%
1.31%
0%
40.75%
13.45%

About Kopran

  • NSE Symbol
  • KOPRAN
  • BSE Symbol
  • 524280
  • ISIN
  • INE082A01010

Similar Stocks to Kopran

Kopran FAQs

Kopran share price is ₹202 As on 21 November, 2024 | 13:53

The Market Cap of Kopran is ₹978.3 Cr As on 21 November, 2024 | 13:53

The P/E ratio of Kopran is 18.5 As on 21 November, 2024 | 13:53

The PB ratio of Kopran is 2 As on 21 November, 2024 | 13:53

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23